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Abstract 
Background: Intracerebral hemorrhage (ICH) in the context of cerebral hyperperfusion 
syndrome (CHS) is an uncommon but potentially lethal complication after carotid 
revascularization for carotid occlusive disease. Information about its incidence, risk 
factors and fatality is scarce. Therefore, we aimed to perform a systematic review and 
meta-analysis focusing on the incidence, risk factors and outcomes of ICH in the context 
of CHS after carotid revascularization.  
Methods: We searched on PubMed and EBSCO host for all studies published in English 
about CHS in the context of carotid revascularization. Two reviewers independently 
assessed each study for eligibility based on predefined criteria. Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed 
and PROSPERO register was made (register number: CRD42016033190), including the 
pre-specified protocol.  
Results: Forty-one studies involving 28956 participants were deemed eligible and 
included in our analysis. The overall quality of the included studies was fair. The pooled 
frequency of ICH in the context of CHS was 38% (95% CI: 26% to 51%, I2=84%, 24 studies) 
and the pooled case-fatality of ICH after CHS was 51% (95% CI: 32% to 71%, I2=77%, 17 
studies). When comparing carotid angioplasty with stenting (CAS) with carotid 
endarterectomy (CEA), post-procedural ICH in the context of CHS was less frequent in 
CEA. ICH following CHS occurred less often in large series and was rare in asymptomatic 
patients. The most common risk factors were periprocedural hypertension and 
ipsilateral severe stenosis.  
Conclusions: ICH as a manifestation of CHS is rare, more frequent after CAS, and 
associated with poor prognosis. Periprocedural control of hypertension can reduce its 
occurrence. 
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1-Introduction 
Ischemic strokes is a major cause of morbidity and mortality worldwide. (12, 33, 53) 
Carotid artery disease contributes to 18-29% of all cases.(59, 66) Carotid invasive 
interventions such as carotid endarterectomy (CEA) and carotid angioplasty with 
stenting (CAS) are widely used to treat carotid artery disease.(6, 26, 62) One potentially 
severe complication is intracerebral hemorrhage (ICH) in the context of cerebral 
hyperperfusion syndrome (CHS).(37) Clinical manifestations of CHS are diverse and 
include symptoms such as throbbing headaches, confusion, focal neurological deficits, 
partial or generalized seizures, among others.(25, 27, 60) Diagnostic  exams such 
computerized tomography scan (CT), magnetic resonance imaging (MRI), transcranial 
Doppler (TCD), single-photon emission computerized tomography (SPECT) and positron 
emission tomography (PET) can be used to confirm or exclude this diagnosis.(3, 11, 24, 
60) The pathophysiology behind CHS is still poorly understood.(41) Three mechanisms 
have been associated with the syndrome: failure of brain vessels’ auto-regulatory 
mechanisms to adapt to the sudden and deregulated increase in cerebral blood flow 
after carotid revascularization in long standing  hypoperfused brains due to severe 
stenosis/obstruction(2, 36, 48, 54, 60);  baroreflex disturbances secondary to carotid 
revascularization (58); disturbances in the trigeminovascular reflex.(35, 60) Despite its 
severity, the knowledge about the frequency, risk factors and prognosis of ICH in the 
context of CHS is scarce. Previous reviews did not specifically addressed the occurrence 
of ICH in the context of CHS .(32, 41) Therefore, we set up to perform a systematic review 
of the existent studies and meta-analytically estimate the frequency of ICH after CHS 
and its case-fatality. 
2-Material and Methods 
2.1-Protocol and registration 
This systematic review was registered at PROSPERO database (CRD42016033190) and 
written in accordance with PRISMA guidelines.(31) 
2.2-Eligibility criteria 
Primary studies involving patients submitted to carotid revascularization (CAS or CEA) 
due to carotid occlusive disease were included. Studies with CEA/CAS preformed for 
other specific conditions, case reports and animal studies; and studies in which the 
definition and frequency of ICH related CHS was not described   were excluded.  
2.3-Information sources 
The search process was performed using the search engines PubMed and EBSCOHost 
(1986 to January 2016). Databases accessed via EBSCOhost include MEDLINE, 
sciencedirect, academic one file, J-stage, general one file, OAlster, expanded academic 
ASAP, China/Asia on demand, SciELO, Scitech conect, MedicLatina and Korean studies 
information study system. Only full-text English-written publications were included. 
2.4-Search strategy and study selection 
The Mesh terms “cerebral hyperperfusion syndrome”, “complications”, “carotid 
revascularization”, “endarterectomy” and “carotid angioplasty” were used to retrieve 
relevant literature.  Studies were selected by two independent investigators. A 
consensus between the authors was used to resolve any disagreements about the 
inclusion of specific studies. 
2.6-Data collection process 
Studies were analysed  by two independent investigators. A consensus between the 
authors was used to resolve any disagreements about the inclusion of specific studies. 
2.7-Data items 
The following items were extracted: type surgical procedure; frequency of CHS with ICH; 
associated risk factors, outcome (case-fatality, morbidity rates). 
2.8-Studies Risk of bias 
The National institutes of Health (NIH) tools were used (15) for quality assessment 
(supplement). Two reviewers performed the assessment independently. Discrepancies 
in the classifications were discussed and agreement achieved.  
2.11-Planned methods of analysis 
Qualitative analysis with quantitative description including all selected studies was 
performed whenever applicable.  To address the risk factors; and for the meta-analysis 
of frequency and case-fatality of ICH after CHS, only large studies (≥ 100 patients) were 
considered. This arbitrary threshold was selected to minimize the effects of substantial 
variability in the diagnostic criteria, time of evaluation and populations included in our 
study. We used Stata/SE 14.0 software for conducting the analysis and to derive forest 
plots. Random-effects meta-analysis weighted by the inverse-variance method was 
performed to estimate pooled frequency and 95% confidence intervals (CI). 
Heterogeneity was assessed with the I2 test. We used a random-effects model as 
substantial heterogeneity between studies results was expected. The limit for statistical 
significance was established at 0.05. 
3-Results 
3.1-Study selection 
Initial search yielded a total of 545 manuscripts (423 publications at EBSCOhost and 122 
publications at PubMed) (Figure 1). After extraction removal of duplicates and studies 
not fulfilling our eligibility criteria, 41 studies were included in the final analysis (Figure 
1).  Reasons for study exclusions were documented at supplement - 1. 
3.2-Study characteristics 
A total of 28.956 participants were included, with studies sample sizes ranging from 26 
to 4.494 participants (Table 1). Eighteen studies (44%) defined both CHS and ICH at 
methods section. (1, 2, 7-9, 16, 19, 20, 22, 24, 29, 34, 42, 44, 46, 47, 61, 65) The 
frequency of ICH after carotid intervention  in studies with less than 100 participants 
ranged from 0% to 4.44%.(4, 8, 14, 17, 18, 21, 22, 24, 40, 46, 48, 64) In studies with 101 
to 1000 participants the range was from 0% to 2.21%.(1, 2, 5, 7, 9, 10, 13, 19, 20, 23, 29, 
30, 34, 39, 42, 43, 51, 55, 57, 65) In studies that included 1001 or more participants a 
range from 0.09% to 0.6% was found.(16, 44, 45, 47, 49, 50, 52, 61, 63) With regard to 
the quality evaluation, the majority were rated as “good” (1, 2, 5, 7, 8, 18, 22, 29, 30, 34, 
50, 65) or fair (4, 9, 10, 13, 16, 17, 19-21, 23, 24, 39, 40, 42-49, 51, 55-57, 63, 64), and 
three were “poor”.(14, 52, 61) The risk of bias was considerable in most studies 
(Supplement 2).(4, 9, 10, 13, 16, 17, 19-21, 23, 24, 39, 42-45, 47, 49, 55, 64) The pooled 
frequency of ICH in the context of CHS was 38% (95% CI: 26% to 51%, I2=84%) (Figure 2) 
3.3-Risk factors  
Table 2 resumes the risk factors found in larger studies (≥ 100 patients). Table 1 shows 
that when comparing CEA and CAS, the frequency of ICH in the context of CHS in large 
studies was higher after CAS, ranging from 0.28% to 4.05%.(1, 7, 9, 19, 30, 39, 42, 47, 
49, 55, 57, 65) In CEA varied from 0% to 2.15%.(2, 5, 9, 10, 13, 16, 18, 20, 23, 29, 34, 43-
45, 47, 61) Also, 73% of the studies involving CAS had a frequency of ICH in the context 
of CHS above 0.5%.(1, 7, 9, 19, 30, 39, 42, 47, 49, 55, 57, 65) In CEA, these frequencies 
occurred in only 26% of the cases.(2, 5, 9, 10, 13, 16, 18, 20, 23, 29, 34, 43-45, 47, 61)  
The “ICH to CHS proportion” has higher after CAS in comparison to CES: 7 out of 11 CAS 
studies (63.6%) had 50% or more hemorrhagic CHS (range 0-100%).(2, 5, 9, 10, 13, 16, 
18, 20, 23, 29, 34, 43-45, 47, 61) In CEA, 5 out of 12 studies (41.6%) had 50% or more 
cases of hemorrhagic CHS (range 0-80%).(2, 5, 9, 10, 13, 16, 18, 20, 23, 29, 34, 43-45, 47, 
61) Post procedure ICH in asymptomatic patients was addressed in 9 large studies (1, 7, 
10, 13, 47, 49, 55, 57, 61) and occurred in three.(47, 57, 61) Overall, periprocedural 
hypertension is the most frequent risk factor, being documented in 4 studies.(16, 20, 47, 
50) Three studies mention ipsilateral severe stenosis as risk factor.(50, 51, 63) Younger 
age was considered a risk factor in 2 studies but denied as a risk factor in other 2 
studies.(16, 47, 51, 63)  
 
3.4-Outcomes 
The mortality of ICH related to CHS ranged from 0% to 100%.(1, 8, 9, 16, 20, 21, 23, 30, 
39, 40, 42, 45, 47, 49, 51, 55, 57, 61, 63-65). In large studies the mortality was ≥ 50% in 
more than half of the studies (range 0 to 100%).(1, 10, 17, 21, 24, 31, 39, 42, 45, 47, 49, 
51, 55, 57, 61, 63, 65) The pooled case-fatality of ICH after CHS was 51% (95% CI: 32% to 
71%, I2=77%) (Figure 3). 
4-Discussion 
This is the first systematic review and meta-analysis addressing the frequency, risk 
factors and outcome of ICH in the context of CHS. Despite being discussed since 
1981(54), no consensual definition exists for CHS and its pathophysiology is still to be 
elucidated.(28, 60) We found a high variation in the frequency of ICH in the context of 
CHS, with a range of 0% to 4.44%.(1, 2, 4, 5, 7-10, 13, 14, 16-24, 29, 30, 34, 39, 40, 42-
52, 55, 57, 61, 63-65) The overall case-fatality associated to ICH in the context of CHS 
was high.(1, 8, 10, 17, 21, 22, 24, 31, 39, 40, 42, 45, 47, 49, 51, 55, 57, 61, 63-65) Of 
notice, the two larger studies reported associated mortality varying from 25.93% to 
57.14%(16, 47). Important variation exists regarding mortality rates when considering 
all studies information (0 to 100%). However, this may be explained by the inclusion of 
different studies designs, samples sizes and the classification criteria used for ICH in the 
context of CHS .  In large studies, the frequency of ICH was higher after CAS in 
comparison to CEA and was rare after asymptomatic carotid disease. The higher “ICH to 
CHS proportion” post CAS CHS further supports the notion that patients with CHS after 
CAS are at increased risk of ICH.(38) The mandatory use of double antiplatelet therapy 
in CAS could contribute to this finding. Indeed, the use of antithrombotics was 
associated with the occurrence of post CAS ICH in two small studies and in one large 
study based on administrative data.(38) Periprocedural hypertension and ipsilateral 
severe stenosis where the commonest risk factors described.(16, 20, 47, 50, 51, 63) This 
data is relevant and stresses the importance of pre and post carotid revascularization 
blood pressure control, particularly in patients with severe stenosis. One frequent bias 
found in the included studies was the lack of definition for CHS with ICH. However, the 
requirement of brain imaging for ICH diagnosis may minimize the impact of this bias for 
the overall comparison. The use of different methodologies and size discrepancies 
between the studies can also explain the variation in the frequency of ICH in the context 
of CHS.(1, 2, 4, 5, 7-10, 13, 14, 16-24, 29, 30, 34, 39, 40, 42-52, 55, 57, 61, 63-65) The 
lack of information regarding associated factors such as use of antithrombotics, time 
interval from ischemic event to revascularization procedure, and presence of chronic 
with matter alterations represent a limitation when evaluating the occurrence of ICH in 
the context of CHS.  
 
5-Conclusion 
This systematic review and meta-analysis showed that ICH in the context of CHS is rare 
in large series, occurs more frequently after CHS secondary to CAS and than post CAS, 
and is generally associated with high case-fatality rate. The main risk factors are 
periprocedural hypertension and ipsilateral severe stenosis. Further studies to better 
describe the contribution of other risk factors are needed. 
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